Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06419959 · ClinicalTrials.gov registry record · NA
NightWare and Cardiovascular Health in Veterans With PTSD
A NA study of Cardiovascular Diseases and Endothelial Dysfunction, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT06419959: Recruiting NA study of Cardiovascular Diseases and Endothelial Dysfunction, sponsored by VA Office of Research and Development.
NCT06419959 is a NA study of Cardiovascular Diseases and Endothelial Dysfunction that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 125 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06419959, a NA study of Cardiovascular Diseases and Endothelial Dysfunction, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about the effectiveness of a prescription wrist-wearable device called NightWare (NW) on improving sleep in Veterans with nightmares related to posttraumatic stress disorder (PTSD). The investigators also want to learn whether it improves cardiovascular health among this population.
Primary Outcome
Sleep questionnaire with a scale of 0 to 21 with a higher score indicating a significant sleep disturbance
Conditions Studied
Interventions
- DEVICE NightWare
Study Locations (1)
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06419959 shows while recruiting
NCT06419959 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which NightWare is the first listed.
NCT06419959 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06419959 about?
NCT06419959 is a clinical study titled "NightWare and Cardiovascular Health in Veterans With PTSD". The purpose of this study is to learn more about the effectiveness of a prescription wrist-wearable device called NightWare (NW) on improving sleep in Veterans with nightmares related to posttraumatic stress disorder (PTSD). The investigators also want to learn whether it improves cardiovascular hea...
What is the current status of trial NCT06419959?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-09-10. Estimated completion is 2026-12-31.
What conditions does trial NCT06419959 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Endothelial Dysfunction, Posttraumatic Stress Disorder (PTSD), Vascular Stiffness, Autonomic Dysfunction.
What interventions are being tested in trial NCT06419959?
The interventions under investigation include: NightWare (DEVICE).
Who is sponsoring clinical trial NCT06419959?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06419959 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06419959's enrollment target sits among peer trials
125 177th of 300 higher than 123 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI